Mechanism of Action

Mechanism of Action

Neutrophil Recruitment and Tumour Clearance: The Innate Immune Response to EBC-46

EBC-46 triggers rapid neutrophil infiltration at the injection site, creating a localised inflammatory response that accelerates tumour clearance within hours.

EBC-46

Diacylglycerol Mimicry: Why EBC-46 Binds PKC with Exceptional Selectivity

EBC-46 mimics the natural lipid messenger diacylglycerol to activate specific PKC isoforms — a molecular trick that explains its targeted anti-tumour effects.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: How EBC-46 Reaches Beyond the Tumour

EBC-46 targets PKC isoforms that regulate mitochondrial function and energy metabolism — a biological dimension that extends the compound's relevance well beyond oncology.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: EBC-46 Beyond the Tumour

The same PKC isoforms EBC-46 activates for anti-tumour effect also regulate mitochondrial membrane dynamics and cellular energy production — a scientifically rich area still awaiting systematic study.

EBC-46

PKC-Delta Activation: The Molecular Switch EBC-46 Flips

Tigilanol tiglate activates PKC-delta by mimicking the diacylglycerol second messenger, triggering simultaneous vascular disruption, immune cascade, and cancer-cell apoptosis within the tumour.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: How EBC-46 May Influence Cellular Bioenergetics

PKC-delta and PKC-epsilon isoforms play opposing roles in mitochondrial function — EBC-46's selective activation may reshape cellular energy production beyond tumour destruction.

EBC-46

Apoptosis vs Necrosis: How EBC-46's Cell Death Pathway Differs from Conventional Chemotherapy

EBC-46 kills cancer through a dual mechanism — activating both apoptotic programming and catastrophic vascular necrosis — that conventional chemotherapy cannot replicate and the immune system amplifies.

EBC-46

PKC Isoforms and Mitochondrial Energy Metabolism: How EBC-46 May Influence Cellular Energetics

Protein kinase C isoforms activated by EBC-46 are intimately connected to mitochondrial function — a link that may explain both anti-tumour effects and the energy-related reports from supplement users.

EBC-46

The Immune Cascade After PKC Activation: How EBC-46 Recruits Neutrophils, Macrophages, and T-Cells

EBC-46 triggers a precisely ordered immune cascade — neutrophil infiltration within hours, macrophage cleanup within days, and adaptive T-cell memory that may prevent recurrence.

EBC-46

Diacylglycerol Mimicry: Why EBC-46 Binds Protein Kinase C With Unusual Selectivity

EBC-46 doesn't force its way into cells — it speaks their language. By mimicking diacylglycerol, the compound activates PKC with a precision that synthetic drugs rarely achieve. Here's the molecular story.

EBC-46

Vascular Disruption Without Systemic Toxicity: How EBC-46 Starves Tumours From Within

EBC-46 destroys the blood vessels feeding a tumour within hours of injection — cutting off oxygen and nutrients while leaving surrounding healthy vasculature intact. Here is the biology behind this precision.

EBC-46

PKC-Delta Activation: The Molecular Switch Behind EBC-46's Anti-Tumour Effect

EBC-46 works by mimicking diacylglycerol to activate PKC-delta, triggering a cascade of vascular disruption and immune recruitment that destroys tumours from within.